Why VeloGene?
Mouse Customize & Embryonic Stem Cell Bank
VeloGene Mouse Customize
TurboMice™ technology can shorten the mouse model customize cycle to as short as 2 months, with the first generation mice being 100% purebred, eliminating the need for breeding and selection.
TurboMice™ Conditional Knock Out
- Homozygous mice: 4~6 months（Cre+fl/fl）
- 4Rs benefit: no chimeras, no breeding selection required
TurboMice™ Humanization
- Humanizing point mutations
- Humanizing domains, such as extracellular domains
- Humanizing the entire gene
- Humanizing multi-gene loci
- Unrivaled speed and convenience
- Homozygous mice: 3~5 months
- 4Rs benefit: no chimeras, no breeding selection required
TurboMice™ Knock Out
- Homozygous mice: 2~4 months
- 4Rs benefit: no chimeras, no breeding selection required.
TurboMice™ Knock In
- Targeted at a ‘Rosa26/H11’ locus
- Reporter mice
- Any target site you wish to knock in Homozygous mice: 3~5 months
- 4Rs benefit: no chimeras, no breeding selection required
TurboMice™ Multi-Side Gene Editing
- Homozygous mice: 4~6 months
- 4Rs benefit: no chimeras, no breeding selection required
TurboMice™ Multi-Point Gene Editing
- Homozygous mice: 3~5 months
- 4Rs benefit: no chimeras, no breeding selection required
VeloGene Embryonic Stem Cell Bank
High Nourishing Capacity
By removing genetic variability, results become more reliable and reproducible. In drug testing, identical mice respond uniformly to treatments, enabling precise cross-lab replication. This strengthens scientific credibility, supports cross-validation, and is vital for discoveries based on stable experimental conditions.
Improved Predictability
With the same DNA in every mouse, researchers can accurately anticipate physical and behavioral traits. In disease modeling, such as Alzheimer’s or cancer, consistent genetic backgrounds yield dependable symptom patterns. This simplifies result interpretation, reduces experimental uncertainty, and enables targeted, efficient studies, streamlining research.
Efficient Drug Screening and Development
High-throughput, well-controlled experiments are possible since all mice share identical genetic profiles. Any variation in drug response can be attributed to the drug, not genetics. This accelerates the identification of effective compounds, reduces false positives, and cuts development costs, shortening pre-clinical timelines for faster human trials.
In-depth Genetic Research
The absence of genetic variability provides a clean background for targeted gene modifications. Researchers can introduce or disable specific genes to observe precise biological effects—crucial in cancer and developmental biology for uncovering gene-disease mechanisms and paving the way for new therapies.
IP Assurance
At VeloGene, we operate on a strict fee-for-service model. All intellectual property (IP) and materials created for your project are 100% yours. We take every measure to safeguard your IP, ensuring no vectors, ES cells, or mouse lines are retained or resold to third parties. This way, you can focus on your research with complete peace of mind.